Indian-origin doctor is new chairman of International Myeloma Foundation
The Hindu
International Myeloma Foundation has selected S Vincent Rajkumar as its chairman. IMF's founder chairman Brian GM Durie will not run for the office in Spring 2024
Renowned scientist, clinician and researcher, S. Vincent Rajkumar, has been appointed as chairman-elect of the Board of Directors of the International Myeloma Foundation (IMF).
Dr. Rajkumar takes over from the current chairman, Brian G.M. Durie, who is not seeking re-election to the post.
Dr. Durie, the co-founder and chairman of the Board of Directors for 33 years, has said that he will not seek re-election as chairman when his current term ends in spring 2024. He will, however, remain a member of the Board, hold the position of Chairman Emeritus and continue to perform his current activities.
“As one of the leading voices in the myeloma community Dr. Rajkumar can carry forward IMF’s mission to connect to the patient and scientific communities to achieve the very best outcomes for myeloma patients everywhere,” Dr. Durie said.
Dr. Rajkumar’s appointment was a unanimous Board decision the IMF said in a press release.
Dr. Rajkumar said he was deeply grateful and honoured to be selected for the role. “Dr. Durie has given decades of his life to the IMF. I will strive to build upon his incredible legacy,” said Dr. Rajkumar, a professor of medicine at Mayo Clinic. He is a member of the National Cancer Institute Myeloma Steering Committee; chair of the myeloma committee besides being the editor-in-Chief of Blood Cancer Journal; and Associate Editor of Leukemia and the European Journal of Haematology.
Dr. Rajkumar has also served as principal investigator of several clinical trials for the treatment of myeloma, including pivotal trials that led to the regulatory approval of thalidomide for the treatment of the disease in the U.S. He has published more than 480 peer-reviewed papers primarily in the field of multiple myeloma and related plasma cell disorders.